COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James R. Baker Jr., MD
Mary H. Weiser Food Allergy Center and Michigan Nanotechnology Institute for Medicine and the Biological Sciences
Study Chair - N. Franklin Atkinson Jr., MD
Graduate Training Program in Clinical Investigation Associate TP Director, Allergy-Immunology Johns Hopkins Asthma & Allergy Center
Study Chair - Rebecca S. Gruchalla, MD, PhD
Division of Allergy and Immunology Departments of Internal Medicine and Pediatrics, University of Texas Southwestern
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arizona Health Sciences, College of Medicine Tucson, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
Tucson, Arizona, United States
- Arkansas Children'S, University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California, Los Angeles Medical Center
Los Angeles, California, United States
- Stanford Medicine, Sean N. Parker Center for Allergy & Asthma Research
Stanford, California, United States
- National Jewish Health
Denver, Colorado, United States
- University Health, University of Miami Health System
Miami, Florida, United States
- University of South Florida Asthma Allergy and Immunology Clinical Research Unit
Tampa, Florida, United States
- Emory University School of Medicine, Emory Healthcare: Emory Clinic Allergy and Immunology
Atlanta, Georgia, United States
- Sinus and Allergy Center of Northwestern University
Chicago, Illinois, United States
- Northshore University Healthsystem, Dermatology Clinical Trials Unit
Skokie, Illinois, United States
- University of Iowa Health Care
Iowa City, Iowa, United States
- Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Health
Ann Arbor, Michigan, United States
- Henry Ford Hospital and Health System
Detroit, Michigan, United States
- Saint Louis University Care Center for Specialized Medicine
St Louis, Missouri, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Mount Sinai Hospital, Department of Medicine, Division of Clinical Immunology
New York, New York, United States
- Rochester Regional Health
Rochester, New York, United States
- North Carolina Translational and Clinical Sciences Institute-Clinical & Translational Research Center (ctrc) at the University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Cleveland Clinic, Allergy & Clinical Immunology
Cleveland, Ohio, United States
- Penn State Health Allergy, Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine Medical Center
Houston, Texas, United States
- University of Virginia Health System: Department of Medicine, Division of Allergy and Immunology
Charlottesville, Virginia, United States
- Virginia Commonwealth University, Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology
Richmond, Virginia, United States
- University of Wisconsin Asthma Allergy Pulmonary Research
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Apr 2021
- Primary completion
- 20 Apr 2022
- Completion
- 27 Apr 2022
- Last update posted
- 12 Aug 2025
- Registered enrollment
- 746
- Registry id
- NCT04761822
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.